In addition, YAP1 enhances p73-dependant apoptosis in response to DNA damage in NSCLC 40, 41, and represents a pharmacological target to enhance the anti-tumour effects of DNA-damaging modalities for urothelial cell carcinoma treatment 42. This evidence concerns the gene YAP1 and non-small cell lung carcinoma.